According to a report by Grand View Research, Inc.; the global next generation sequencing (NGS) market is anticipated to reach USD 21.4 billion by 2025. High demand for efficient and rapid genomic sequencing methodologies is anticipated to propel market over the forecast period (2014 to 2025).
Growing automation in pre-sequencing is estimated to boost growth of market for next generation sequencing over the next few years. Increasing use of novel platforms to develop personalized medicine through medical analytics at genetic level can further fuel demand for NGS. Rising R&D activities in proteomics, metabolomics, and transcriptomics are likely to surge demand for NGS. Launch of novel products and services can fuel growth. Growing inclination of drug developers and scientists towards NGS technology to implement personalized medicine is projected to further propel market during the forecast period.
Full Research Report On Next Generation Sequencing (NGS) Market Analysis: www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market
UK NGS market revenue, by technology, 2013 – 2024 (USD Million)
The worldwide next generation sequencing market can be segregated on the basis of application, technology, workflow, end-use, and region. Based on application, the market can be categorized into reproductive health, oncology, metagenomics, agrigenomics, consumer genomics, and clinical investigation. Oncology is estimated to witness significant growth during the forecast period. Rapid development of sequencing capabilities is expected to enable targeted sequence determination of number of cancer genes. This can enable oncologists to access genetic information of some less accessible dense gene clusters related to cancer cells and tumors.
Based on technology, the market can be classified into targeted sequencing, whole genome sequencing, and whole exome sequencing. Targeted sequencing dominated the market in terms of overall market share in 2015. Numerous benefits associated with smaller dataset and reduced sequencing costs can be attributed to this growth. In addition, rise in protein expression analysis projects attributed to presence of large sets of DNA-based sequence data can fuel growth.
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Global next generation sequencing market by applications, 2015 & 2025 (USD Million)
Whole genome sequencing which includes genome, microbial, and de novo genome applications is anticipated to expand at a significant CAGR over the forecast period. Increasing number of research programs aimed at mapping human and non-human whole genomes combined with reducing costs can fuel growth. Based on workflow, the market can be classified into sequencing and pre-sequencing. In 2015, sequencing dominated the market and accounted for the largest market share and is predicted to grow at similar pace during the forecast period.
Based on end-use, the market for next generation sequencing can be classified into clinical research, academic research, hospitals and clinics, pharmaceutical and biotechnology entities, and others. Application in research projects in universities and research centers is expected to drive the segment largest in near future. Increasing R&D projects and provision of on-site bioinformatics courses involving workshops on practical implementation of NGS and data analytics can drive market during the forecast period.
Clinical diagnostics is expected to contribute well to overall market growth over the forecast period. Rising adoption of NGS-based small scale platforms for clinical diagnostics is projected to fuel market expansion. Key market players are likely to target small laboratories and clinics by introducing high performance small benchtop sequencers that can enhance adoption of next generation sequencing in disease diagnostics and monitoring procedures.
Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa (MEA). In 2015, North America dominated the market and accounted for largest market share owing to presence of advanced healthcare framework. In addition, high R&D investments for genomic and proteomic sequence determination for biomarkers research can fuel regional market growth in the forthcoming years.
Asia Pacific is estimated to expand at a CAGR of 18% during the forecast period attributed to increasing investments in healthcare infrastructure coupled with growing consumer awareness. In addition, increasing per capita and residual income levels can positively influence regional market growth during the forecast period.
Some of the leading companies operating in the global next generation sequencing (NGS) market are Pacific Biosciences, Beijing Genomics Institute, Biomatters Limited, Helicos BioSciences, and Thermo Fisher Scientific.
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States